Key Financial Data Of Group

TAIKO PHARMACEUTICAL CO., LTD. - Filing #7270730

Concept As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
As at
2020-12-31
2020-04-01 to
2020-12-31
2020-04-01 to
2020-12-31
Key financial data of group
Business results of group
Net sales
5,546,000,000 JPY
6,292,000,000 JPY
6,120,000,000 JPY
5,431,000,000 JPY
5,040,000,000 JPY
4,644,000,000 JPY
10,599,000,000 JPY
11,299,000,000 JPY
17,089,000,000 JPY
17,582,000,000 JPY
Ordinary profit (loss)
947,000,000 JPY
688,000,000 JPY
-1,248,000,000 JPY
-1,331,000,000 JPY
-3,352,000,000 JPY
-3,274,000,000 JPY
-5,862,000,000 JPY
-6,131,000,000 JPY
5,469,000,000 JPY
5,454,000,000 JPY
Profit (loss) attributable to owners of parent
898,000,000 JPY
-3,611,000,000 JPY
-4,895,000,000 JPY
-9,594,000,000 JPY
3,851,000,000 JPY
Comprehensive income
1,147,000,000 JPY
-3,466,000,000 JPY
-4,796,000,000 JPY
-9,467,000,000 JPY
3,840,000,000 JPY
Net assets
7,412,000,000 JPY
7,964,000,000 JPY
6,739,000,000 JPY
6,020,000,000 JPY
8,044,000,000 JPY
7,491,000,000 JPY
12,413,000,000 JPY
12,807,000,000 JPY
22,188,000,000 JPY
22,781,000,000 JPY
Total assets
12,125,000,000 JPY
12,914,000,000 JPY
13,220,000,000 JPY
12,249,000,000 JPY
15,046,000,000 JPY
14,306,000,000 JPY
21,925,000,000 JPY
22,535,000,000 JPY
30,966,000,000 JPY
31,757,000,000 JPY
Net assets per share
147.67
158.67
134.93
120.52
184.60
171.91
284.83
293.88
512.14
525.83
Basic earnings (loss) per share
23.34
17.90
-76.25
-78.63
-112.26
-113.64
-213.03
-220.52
89.57
89.18
Diluted earnings per share
89.21
88.82
Equity-to-asset ratio
0.611 xbrli:pure
0.617 xbrli:pure
0.510 xbrli:pure
0.491 xbrli:pure
0.535 xbrli:pure
0.524 xbrli:pure
0.566 xbrli:pure
0.568 xbrli:pure
0.716 xbrli:pure
0.717 xbrli:pure
Rate of return on equity
0.174 xbrli:pure
0.122 xbrli:pure
-0.489 xbrli:pure
-0.551 xbrli:pure
-0.470 xbrli:pure
-0.498 xbrli:pure
-0.536 xbrli:pure
-0.539 xbrli:pure
0.189 xbrli:pure
0.183 xbrli:pure
Price-earnings ratio
14.18 xbrli:pure
18.49 xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
18.00 xbrli:pure
18.08 xbrli:pure
Net cash provided by (used in) operating activities
362,000,000 JPY
-307,000,000 JPY
-1,994,000,000 JPY
-1,595,000,000 JPY
-1,516,000,000 JPY
Net cash provided by (used in) investing activities
-5,000,000 JPY
1,166,000,000 JPY
190,000,000 JPY
-1,622,000,000 JPY
-2,759,000,000 JPY
Net cash provided by (used in) financing activities
-1,181,000,000 JPY
1,539,000,000 JPY
-997,000,000 JPY
3,959,000,000 JPY
-649,000,000 JPY
Cash and cash equivalents
4,532,000,000 JPY
5,244,000,000 JPY
2,797,000,000 JPY
5,521,000,000 JPY
4,698,000,000 JPY
Number of employees
44 xbrli:pure
143 xbrli:pure
122 xbrli:pure
27 xbrli:pure
186 xbrli:pure
187 xbrli:pure
159 xbrli:pure
xbrli:pure
xbrli:pure
27 xbrli:pure
214 xbrli:pure
37 xbrli:pure
208 xbrli:pure
178 xbrli:pure
210 xbrli:pure
175 xbrli:pure
226 xbrli:pure
264 xbrli:pure
237 xbrli:pure
274 xbrli:pure
Average number of temporary employees
2 xbrli:pure
5 xbrli:pure
5 xbrli:pure
3 xbrli:pure
10 xbrli:pure
7 xbrli:pure
7 xbrli:pure
xbrli:pure
xbrli:pure
3 xbrli:pure
10 xbrli:pure
2 xbrli:pure
15 xbrli:pure
15 xbrli:pure
22 xbrli:pure
22 xbrli:pure
23 xbrli:pure
23 xbrli:pure
60 xbrli:pure
60 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.